263 related articles for article (PubMed ID: 27879630)
1. Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.
Ferreira MR; Moreira GM; Cunha CE; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27879630
[No Abstract] [Full Text] [Related]
2. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
[TBL] [Abstract][Full Text] [Related]
3. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
[TBL] [Abstract][Full Text] [Related]
4. Measurement over 1 Year of Neutralizing Antibodies in Cattle Immunized with Trivalent Vaccines Recombinant Alpha, Beta and Epsilon of
Galvão CC; Barbosa JD; Oliveira CMC; Otaka DY; Silva PRO; Ferreira MRA; Moreira Júnior C; Conceição FR; Salvarani FM
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564599
[TBL] [Abstract][Full Text] [Related]
5. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for
Ding G; Bai J; Feng B; Wang L; Qiao X; Zhou H; Jiang Y; Cui W; Tang L; Li Y; Xu Y
Virulence; 2019 Dec; 10(1):754-767. PubMed ID: 31429624
[No Abstract] [Full Text] [Related]
6. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis.
Wang Y; Miao Y; Hu LP; Kai W; Zhu R
Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084
[TBL] [Abstract][Full Text] [Related]
7. Inactivated recombinant Escherichia coli as a candidate vaccine against Clostridium perfringens alpha toxin in sheep.
Ferreira MRA; Motta JF; Azevedo ML; Dos Santos LM; Júnior CM; Rodrigues RR; Donassolo RA; Reis ADSB; Barbosa JD; Salvarani FM; Moreira ÂN; Conceição FR
Anaerobe; 2019 Oct; 59():163-166. PubMed ID: 31299397
[TBL] [Abstract][Full Text] [Related]
8. Generation of recombinant baculovirus expressing atoxic C-terminal CPA toxin of Clostridium perfringens and production of specific antibodies.
Forti K; Cagiola M; Pellegrini M; Anzalone L; Di Paolo A; Corneli S; Severi G; De Giuseppe A
BMC Biotechnol; 2020 Jan; 20(1):7. PubMed ID: 31992276
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits.
Zhao L; Guo Z; Liu J; Wang Z; Wang R; Li Y; Wang L; Xu Y; Tang L; Qiao X
Vaccine; 2017 Jul; 35(32):4010-4021. PubMed ID: 28625525
[TBL] [Abstract][Full Text] [Related]
10. Immunization of sheep with a recombinant vaccine containing immunogenic nontoxic domains of Clostridium perfringens alpha and beta toxins.
Rodrigues Rodrigues R; Freitas Motta J; Alves Ferreira MR; Moreira Júnior C; Ferreira Alves ML; Costa AV; Andrade Bilhalva M; Amaral Donassolo R; Cancela Galvão C; Silva Martins FM; Masiero Salvarani F; Rochedo Conceição F
Microb Pathog; 2023 Sep; 182():106269. PubMed ID: 37516212
[TBL] [Abstract][Full Text] [Related]
11. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
[TBL] [Abstract][Full Text] [Related]
12. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
[TBL] [Abstract][Full Text] [Related]
13. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
Jiang Z; De Y; Chang J; Wang F; Yu L
Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against pathogenic clostridia in animals: a review.
Abdolmohammadi Khiav L; Zahmatkesh A
Trop Anim Health Prod; 2021 Apr; 53(2):284. PubMed ID: 33891221
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
Kaushik H; Dixit A; Garg LC
Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and Comparison of Clostridium Epsilon-Alpha Fusion Gene Expression Using Different Commercial Expression Vector.
Sepehrifar HR; Pilehchian Langroudi R; Ataei S; Haddadi A
Arch Razi Inst; 2021 Mar; 76(1):7-16. PubMed ID: 33818953
[TBL] [Abstract][Full Text] [Related]
17. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Clostridium perfringens epsilon toxin recombinant bacterin in rabbit and ruminants.
Ferreira MRA; Dos Santos FD; da Cunha CEP; Moreira C; Donassolo RA; Magalhães CG; Belo Reis AS; Oliveira CMC; Barbosa JD; Leite FPL; Salvarani FM; Conceição FR
Vaccine; 2018 Nov; 36(50):7589-7592. PubMed ID: 30389190
[No Abstract] [Full Text] [Related]
19. In vitro characterization and immunogenicity of chitosan nanoparticles loaded with native and inactivated extracellular proteins from a field strain of Clostridium perfringens associated with necrotic enteritis.
Akerele G; Ramadan N; Renu S; Renukaradhya GJ; Shanmugasundaram R; Selvaraj RK
Vet Immunol Immunopathol; 2020 Jun; 224():110059. PubMed ID: 32408182
[TBL] [Abstract][Full Text] [Related]
20. Humoral Immune Response Evaluation in Horses Vaccinated with Recombinant
Freitas NFQR; Otaka DY; Galvão CC; de Almeida DM; Ferreira MRA; Moreira Júnior C; Hidalgo MMMH; Conceição FR; Salvarani FM
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
